London-based PE firm Actis Capital in talks to buy minority stake in Concord Biotech

London-based PE firm Actis Capital in talks to buy minority stake in Concord Biotech

Visual from the company website

Reghu Balakrishnan

22 September, 2015

Actis CapitalConcord BiotecIDFC CapitalLaurus LabsMatrix LabsMylan NVParas Pharmaceuticals Ltdprivate equityRakesh JhunjhunwalaRanbaxy LaboratoriesRanbaxy Laboratories LtdRare EnterprisesReckitt Benckiser Group Plc.Singhi AdvisorsSterling HospitalsSudhir VaidSymbiotec Pharmalab LtdWarburg Pincus Llc

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.